We recommend that you upgrade to the latest version of your browser.
logo Helse Bergen

Fagseminar

MRCRM seminar series - September 2023

Dr. Christopher Kvistad is a senior physician and researcher at the Dept. of Neurology/Neuro-Sysmed. He will present the clinical study SMART-MS, where patients with multiple sclerosis (MS) are treated with mesenchymal stem cells (MSCs).

Passed
19.
September
2023
  1. 19. Sep 2023, 2:30 PM - 3:30 PM

Time and place

When

  1. 19. Sep 2023, 2:30 PM - 3:30 PM

Event type

Fagseminar

Organizer

MRCRM

TITLE

SMART-MS - Mesenchymal stem cells as regenerative treatment in multiple sclerosis


ABSTRACT

Neurological disorders are the leading cause of disability worldwide. Despite their high prevalence and socioeconomic burden, there is still no treatment available to directly promote repair of damage to the central nervous system (CNS) and thereby reverse neurological disability. A frequent cause of CNS injury and neurological disability in young adults is multiple sclerosis (MS).  

 
Mesenchymal stem cells (MSCs) have the potential to induce CNS repair through multiple neuroregenerative mechanisms, including remyelination, immunomodulation and stimulation of endogenous neural stem cells. 
 
The SMART-MS study aims to investigate the neuroregenerative potential of treatment with MSCs in MS and to increase the understanding of the underlying mechanisms of action. 
 

ABOUT THE SPEAKER

Portrait Christopher Elnan Kvistad. Photo
Photo: Anne Sidsel Herdlevær

 

 

Dr. Christopher Elnan Kvistad is a researcher at Neuro-Sysmed and a senior consultant in Neurology at Haukeland University Hospital. He is one of the principal investigators in the SMART-MS clinical trial. 

Contact